• OrganoClick posted Q2 net sales of SEK 22.1 million, down 26% year on year; gross margin rose 7 percentage points to 28.6%.
• Operating loss narrowed to SEK 2.1 million; operating cash flow fell to SEK 1.8 million.
• H1 net sales dropped 24.46% to SEK 49.4 million; operating loss narrowed to SEK 1.8 million.
• Gross margin in H1 increased 6 percentage points to 29.6%; operating cash flow turned positive to SEK 1.5 million.
• Completed a new share issue raising about SEK 33 million; proceeds used mainly to reduce debt, targeting SEK 2-3 million lower interest costs by 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrganoClick AB published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.